Hope For Newly Diagnosed Ovarian Cancer Patients– PARP Inhibitor Niraparib Now FDA Approved For Front-Line Ovarian Cancer Treatment

Updated May 25th, 2020

Hope For Newly Diagnosed Ovarian Cancer Patients– PARP Inhibitor Niraparib Now FDA Approved For Front-Line Ovarian Cancer Treatment

NOW
PLAYING
Cancer Screenings Down 95 Percent During COVID Pandemic
NOW
PLAYING
Medicare No Longer Covers Brain-Cancer Drug Gleostine
NOW
PLAYING
Anderson Cooper Breaks Down During Tribute To Producer Who Lost Battle With Appendix Cancer
NOW
PLAYING
High Schooler Sinks Game-Winning Shot After Nearly Losing Leg In Cancer Battle
NOW
PLAYING
CNN's Christiane Amanpour Saw Cancer Destroy the Life of Best Friend John F Kennedy Jr.;
NOW
PLAYING
Recall of Ventilators Over Potential Cancer-Causing Toxins Raises Questions

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.